Pricing Log in Create free account

Inovio Pharmaceuticals, Inc. (INO) vs NervGen Pharma Corp. (NGEN)

Inovio Pharmaceuticals, Inc. and NervGen Pharma Corp. are both Biotechnology companies. NervGen Pharma Corp. is the larger, with a market value of $143.1M against $125.6M — 1.1× the size. Across the 8 metrics below, NervGen Pharma Corp. leads on 6 and Inovio Pharmaceuticals, Inc. on 2.

Valuation

Metric INO NGEN Biotechnology median
P/E n/m n/m 10.60
P/S 258.10 n/m 9.40
P/B 22.78 3.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 206.11 n/m 9.02
Earnings yield (94.67%) (17.89%) (32.88%)
Free cash flow yield (80.41%) (14.96%) (23.13%)

Profitability

Metric INO NGEN Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (409.87%) (94.85%) (51.96%)
Return on assets (114.64%) (40.66%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INO NGEN Biotechnology median
Revenue growth (TTM) (54.82%) — 6.76%
EPS growth (last fiscal year) 54.18% (68.14%) 29.88%
Revenue growth, 5-year CAGR (61.18%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric INO NGEN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.00 2.07 4.97
Net debt to EBITDA 0.70 0.95 1.01

Dividend

Metric INO NGEN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INO NGEN Biotechnology median
Market cap 125.63m 143.13m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack